Prevention inherent in services for women with schizophrenia

Canadian Journal of Psychiatry

Volumn 53, Issue 5, 2008, Pages 332-341

  Seeman, Mary V ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Prenatal care; Prevention; Schizophrenia; Women

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BUTYROPHENONE DERIVATIVE; CYANOCOBALAMIN; FOLIC ACID; NEUROLEPTIC AGENT; PHENOTHIAZINE;

ADDICTION; BEHAVIOR DISORDER; BREAST FEEDING EDUCATION; CHILD HEALTH CARE; CHILD WELFARE; CONGENITAL MALFORMATION; CONTRACEPTION; CULTURAL COMPETENCE; DEVELOPMENTAL DISORDER; DISTRESS SYNDROME; DOMESTIC VIOLENCE; DOSE CALCULATION; DRUG BLOOD LEVEL; ENURESIS; FEMALE SEXUAL DYSFUNCTION; FETUS OUTCOME; GENETIC COUNSELING; GRAMMAR; GROUPS BY AGE; HEART ARRHYTHMIA; HEART DISEASE; HIP FRACTURE; HUMAN; HYPERPROLACTINEMIA; IMMIGRATION; IMMOBILIZATION; INCOME; INFECTION RISK; INTERVENTION STUDY; LANGUAGE DISABILITY; MATERNAL CARE; MATERNAL SMOKING; MEDICAL ETHICS; MEDICAL LITERATURE; MENTAL DISEASE; MENTAL HEALTH CARE; METABOLIC SYNDROME X; NEURAL TUBE DEFECT; OBESITY; OBSTETRICS; OSTEOPOROSIS; PATIENT EDUCATION; PATIENT SAFETY; PLACENTAL TRANSFER; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL EXPOSURE; PREVENTIVE MEDICINE; PUERPERAL PSYCHOSIS; QUALITY OF LIFE; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELECTIVE ATTENTION; SIDE EFFECT; SINGLE PARENT; SOCIAL SUPPORT; SUBSTANCE ABUSE; TORSADE DES POINTES; UNEMPLOYMENT; VERBAL MEMORY; VISUAL DISORDER; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WALKING DIFFICULTY; WEIGHT GAIN; WINTER; WOMEN'S HEALTH;

EID: 45249103111     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805300508     Document Type: Review

References (132)

1. Howard LM. Fertility and pregnancy in women with psychotic disorders. Eur J Obstet Gynecol Reprod Biol. 2005;119:3-10.
2. Jablensky AV, Morgan V, Zubrick SR, et al. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162:79-91.
3. Howard LM, Goss C, Leese M, et al. Medical outcome of pregnancy in women with psychotic disorders and their infants in the first year after birth. Br J Psychiatry. 2002;182:63-67.
4. Nilsson E, Lichtenstein P, Cnattingius S, et al. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res. 2002;58:221-229.
5. Webb R, Abel K, Pickles A, et al. Mortality in offspring of parents with psychotic disorders: a critical review and meta-analysis. Am J Psychiatry. 2005;162:1045-1056.
6. Webb RT, Abel KM, Pickles AR, et al. Mortality risk among offspring of psychiatric inpatients: a population-based follow-up to early adulthood. Am J Psychiatry. 2006;163:2170-2177.
7. Austin JC, Honer WG. The genomic era and serious mental illness: a potential application for psychiatric genetic counseling. Psychiatr Serv. 2007;58:254-261.
8. Mortensen PB, Pederson B, Westergaard T, et al. Effects of family history and place and season of birth on the risk of schizophrenia. NEJM. 1999;340:603-608.
9. Davies G, Welham J, Chant D, et al. A systematic review and meta-analysis of northern hemisphere season of birth studies in schizophrenia. Schizophr Bull. 2003;29:587-593.
10. Miller LJ, Finnerty M. Family planning knowledge, attitudes and practices in women with schizophrenic spectrum disorders. J Psychosom Obstet Gynecol. 1998;19:210-217.
11. Abbott J, Feldhaus KM, Houry D, et al. Emergency contraception: what do our patients know? Ann Emerg Med. 2004;43:376-381.
12. Coverdale JH, Bayer TL, McCullough LB, et al. Respecting the autonomy of chronic mentally ill women in decisions about contraception. Hosp Community Psychiatry. 1993;44:671-674.
13. Neinstein LS, Katz B. Psychiatrically impaired patients often exposed to pregnancy risk. Contracept Technol Update. 1985;6:88-90.
14. Brown AS, Bottiglieri T, Schaefer CA, et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry. 2007;64:31-39.
15. Picker JD, Coyle JT. Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? Harv Rev Psychiatry. 2005;13:197-205.
16. Fleming A. The role of folate in the prevention of neural tube defects: human and animal studies. Nutr Rev. 2001;59:S13-S20.
17. Koren G. Maternal obesity and risk of neural tube defects. Can Fam Physician. 2001;47:1385-1387.
18. Koren G, Cohn T, Chitayat D, et al. Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry. 2002;159:136-137.
19. Watson PE, McDonald BW. Seasonal variation of nutrient intake in pregnancy: effects on infant measures and possible influence on diseases related to season of birth. Eur J Clin Nutr. 2007;61:1271-1280.
20. Babulas V, Factor-Litvak P, Goetz R, et al. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry. 2006;163:927-929.
21. Nahmias AJ, Nahmias SB, Danielsson D. The possible role of transplacentally-acquired antibodies to infectious agents, with molecular mimicry to nervous system sialic acid epitopes, as causes of neurodevelopmental disorders: prevention and vaccine implications. Clin Dev Immun. 2006;13:167-183.
22. Tough S, Tofflemire K, Clarke M, et al. Do women change their drinking behaviors while trying to conceive? An opportunity for preconception counseling. Clin Med Res. 2006;4:97-105.
23. McCreadie RG, Scottish Comorbidity Study Group. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry. 2002;181:321-325.
24. Green CA. Gender and use of substance abuse treatment services. Alcohol Res Health. 2006;29:55-62.
25. Muller C. Liver, alcohol and gender. Wien Med Wochenschr. 2006;156:523-526.
26. D'Souza DC, Gil RB, Madonick S, et al. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharm. 2006;31:2767-2775.
27. Schofield D, Tennant C, Nash L, et al. Reasons for cannabis use in psychosis. Aust N Z J Psychiatry. 2006;40:570-574.
28. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal Bioanal Chem. 2007;388:1455-1465.
29. Kelly C, McCreadie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry. 1999;156:1751-1757.
30. Morris CD, Giese AA, Turnbull JJ, et al. Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatr Serv. 2006;57:1035-1038.
31. Tidey JW, Rohsenow DJ, Kaplan GB, et al. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend. 2005;80:259-265.
32. Benowitz NL, Lessov-Schlaggar CN, Swan GE, et al. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharm Therap. 2006;79:480-488.
33. Kalinka J, Hanke W, Sobala W. Impact of prenatal tobacco smoke exposure, as measured by midgestation serum cotinine levels, on fetal biometry and umbilical flow velocity waveforms. Am J Perinat. 2005;22:41-47.
34. Okah FA, Hoff GL, Dew P, et al. Cumulative and residual risks of small for gestational age neonates after changing pregnancy-smoking behaviors. Am J Perinat. 2007;24:191-196.
35. Nilsson E, Lichtenstein P, Cnattingius S, et al. Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res. 2002;58:221-229.
36. Gurpegui M, Aguilar MC, Martinez-Ortega JM, et al. Fewer but heavier caffeine consumers in schizophrenia: a case-control study. Schizophr Res. 2006;86:276-283.
37. Conway KS, Kutinova A. Maternal health: does prenatal care make a difference? Health Econ. 2006;15:461-488.
38. Devane CL, Stowe ZN, Donovan JL, et al. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. J Psychopharm. 2006;20(4 Suppl):54-59.
39. Webb RT, Howard L, Abel KM. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev. 2004;(2):CD004411.
40. Patton SW, Misri S, Corral MR, et al. Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can J Psychiatry. 2002;47:959-965.
41. Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother. 2004;38:1265-1271.
42. McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66:444-449.
43. Trixler M, Gáti A, Fekete S, et al. Use of antipsychotics in the management of schizophrenia during pregnancy. Drugs. 2005;65:1193-1206.
44. Seeman MV, Cohen R. A service for women with schizophrenia. Psychiatr Serv. 1998;49:674-677.
45. Verdoux H, Sutter AL. Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology. Am J Med Gen. 2002;114:898-905.
46. Ekstrom A, Nissen E. A mother's feelings for her infant are strengthened by excellent breastfeeding counseling and continuity of care. Pediatrics. 2006;118:e309-314.
47. Proctor A, Jenkins TR, Loeb T, et al. Patient satisfaction with 3 methods of postpartum contraceptive counseling: a randomized, prospective trial. J Reprod Med. 2006;51:377-382.
48. Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health (Larchmt). 2006;15:352-368.
49. Konnecke R, Wening U, Ropeter D, et al. [Developmental conditions and subjective experiences of children with a schizophrenic parent - qualitative and quantitative studies from the Mannheim Study of Children at Risk.] Psychiatr Prax. 2006;33:269-276.
50. Ostman M, Hansson L. Children in families with a severely mentally ill member. Prevalence and needs for support. Soc Psychiatry Psychiatr Epidemiol. 2002;37:243-248.
51. Henriksson KM, McNeil TF. Health and development in the first 4 years of life in offspring of women with schizophrenia and affective psychoses: Well-Baby Clinic information. Schizophr Res. 2004;70:39-48.
52. Schubert EW, McNeil TF. Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis. Am J Psychiatry. 2005;162:758-766.
53. Keri S, Must A, Kelemen O, et al. Development of visual motion perception in children of patients with schizophrenia and bipolar disorder: a follow-up study. Schizophr Res. 2006;82:9-14.
54. Marcus J, Hans SL, Auerbach JG, et al. Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioral deficits at school age. Arch Gen Psychiatry. 1993;50:797-809.
55. Hans SL, Marcus J, Nuechterlein KH, et al. Neurobehavioral deficits at adolescence in children at risk for schizophrenia: the Jerusalem Infant Development Study. Arch Gen Psychiatry. 1999;56:741-748.
56. Hans SL, Auerbach JG, Auerbach AG, et al. Development from birth to adolescence of children at-risk for schizophrenia. J Child Adolesc Psychopharm. 2005;15:384-394.
57. Whitaker RC, Orzol SM, Kahn RS. Maternal mental health, substance use, and domestic violence in the year after delivery and subsequent behavior problems in children at age 3 years. Arch Gen Psychiatry. 2006;63:551-560.
58. Schubert EW, McNeil TF. Prospective study of adult mental disturbance in offspring of women with psychosis. Arch Gen Psychiatry. 2003;60:473-480.
59. Erlenmeyer-Kimling L, Squires-Wheeler E, Adamo UH, et al. The New York High-Risk Project. Psychoses and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. Arch Gen Psychiatry. 1995;52:857-865.
60. Niemi LT, Suvisaari JM, Haukka JK, et al. Cumulative incidence of mental disorders among offspring of mothers with psychotic disorder. Results from the Helsinki High-Risk Study. Br J Psychiatry. 2004;185:11-17.
61. Schubert EW, McNeil TF. Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. Am J Psychiatry. 2004;161:1030-1037.
62. Chandra PS, Bhargavaraman RP, Raghunandan VN, et al. Delusions related to infant and their association with mother-infant interactions in postpartum psychotic disorders. Arch Womens Ment Health. 2006;9:285-288.
63. Abel KM, Webb RT, Salmon MP, et al. Prevalence and predictors of parenting outcomes in a cohort of mothers with schizophrenia admitted for joint mother and baby psychiatric care in England. J Clin Psychiatry. 2005;66:781-789.
64. Fox V. First person account: schizophrenia and motherhood. Schizophr Bull. 2004;30:763-765.
65. Mowbray CT, Oyserman D, Bybee D. Mothers with serious mental illness. New Dir Ment Health Serv. 2000;88:73-91.
66. Oyserman D, Mowbray CT, Meares PA, et al. Parenting among mothers with a serious mental illness. Am J Orthopsychiatry. 2000;70:296-315.
67. Oyserman D, Bybee D, Mowbray C, et al. When mothers have serious mental health problems: parenting as a proximal mediator. J Adolesc. 2005;28:443-463.
68. Grube M, Dorn A. [Parenthood and Mental Illness.] Psychiatr Prax. 2007;34:66-71.
69. Craig T, Bromet EJ. Parents with psychosis. Ann Clin Psychiatry. 2004;16:35-39.
70. Howard LM, Goss C, Leese M, et al. The psychosocial outcome of pregnancy in women with psychotic disorders. Schizophr Res. 2004;71:49-60.
71. Davies B, Allen D. Integrating 'mental illness' and 'motherhood': the positive use of surveillance by health professionals. A qualitative study. Int J Nurs Stud. 2007;44:365-376.
72. Anderson CM, Robins CS, Greeno CG, et al. Why lower income mothers do not engage with the formal mental health care system: perceived barriers to care. Qual Health Res. 2006;16:926-943.
73. Seeman MV. Relational ethics: when mothers suffer from psychosis. Arch Womens Ment Health. 2004;7:201-210.
74. Seeman MV. Mothers and fetuses: competing or conjoint rights? Enfants à protéger; parents à aider; des univers à rapprocher [Protecting children, helping adults: bringing two worlds closer together]. Chamberland C, Léveillé S, Trocmé N, editors. Québec (QC): Presses de l'Université du Québec; 2007. Chapter 8, p 149-164.
75. Coverdale JH, McCullough LB, Chervenak FA. Assisted and surrogate decision making for pregnant patients who have schizophrenia. Schizophr Bull. 2004;30:659-664.
76. de Nesnera A, Grandfield S, Cummings K, et al. Abortion: a psychiatric patient's right to choose. J Psychosoc Nurs Ment Health Serv. 2000;38:9-12.
77. Dudzinski DM. Compounding vulnerability: pregnancy and schizophrenia. Am J Bioeth. 2006;6:W1-14.
78. Dudzinski DM, Sullivan M. When agreeing with the patient is not enough: a schizophrenic woman requests pregnancy termination. Gen Hosp Psychiatry. 2004;26:475-480.
79. Mahowald M, Abernethy V. When a mentally ill woman refuses abortion. Hastings Center Rep. 1985;15:22-23.
80. McCullough LB, Coverdale JH, Chervenak FA. Ethical challenges of decision making with pregnant patients who have schizophrenia. Am J Obstet Gynecol. 2002;187:696-702.
81. Brenner B, Burnet P. Court ordered obstetric intervention: a commentary. N Z Med J. 1995;108:431-432.
82. Goodman LA, Rosenberg SD, Mueser KT, et al. Physical and sexual assault history in women with serious mental illness: prevalence, correlates, treatment, and future research directions. Schizophr Bull. 1997;23:685-696.
83. Teplin LA, McClelland GM, Abram KM, et al. Crime victimization in adults with severe mental illness: comparison with the National Crime Victimization Survey. Arch Gen Psychiatry. 2005;62:911-921.
84. Bailey BA, Daugherty RA. Intimate partner violence during pregnancy: incidence and associated health behaviors in a rural population. Matern Child Health J. 2007;11:495-503.
85. Fitzgerald PB, de Castella AR, Filia KM, et al. Victimization of patients with schizophrenia and related disorders. Aust N Z J Psychiatry. 2005;39:169-174.
86. Honkonen T, Henriksson M, Koivisto AM, et al. Violent victimization in schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2004;39:606-612.
87. Mezey G, Hassell Y, Bartlett A. Safety of women in mixed-sex and single-sex medium secure units: staff and patient perceptions. Br J Psychiatry. 2005;187:579-582.
88. Waddell A, Ross L, Ladd L, et al. Safe minds-perceptions of safety in a rehabilitation clinic for serious persistent mental illness. Int J Psychosoc Rehab. 2006;11:4-10.
89. Koponen H, Rantakallio P, Veijola J, et al. Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:9-13.
90. Morgan C, Fisher H. Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma - a critical review. Schizophr Bull. 2007;33:3-10.
91. Choi SH, Kang SB, Joe SH. Changes in premenstrual symptoms in women with schizophrenia: a prospective study. Psychosom Med. 2001;63:822-829.
92. Hallonquist JD, Seeman MV, Lang M, et al. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry. 1993;33:207-209.
93. Harris AH. Menstrually related symptom changes in women with schizophrenia. Schizophr Res. 1997;27:93-99.
94. Hsiao MC, Hsiao CC, Liu CY. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psychiatry Clin Neurosci. 2004;58:186-190.
95. Lande RG, Karamchandani V. Chronic mental illness and the menstrual cycle. J Am Osteopath Assoc. 2002;102:655-659.
96. Coverdale JH, Aruffo JF. AIDS and family planning counseling of psychiatrically ill women in community mental health clinics. Community Ment Health J. 1992;28:13-20.
97. Coverdale JH, Bayer TL, McCullough LB, et al. Sexually transmitted disease prevention services for female chronically mentally ill patients. Community Ment Health J. 1995;31:303-315.
98. Coverdale JH, Turbott SH, Roberts H. Family planning needs and STD risk behaviours of female psychiatric out-patients. Br J Psychiatry. 1997;171:69-72.
99. Gottesman II, Groome CS. HIV/AIDS risks as a consequence of schizophrenia. Schizophr Bull. 1997;23:675-684.
100. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull. 1997;23:623-635.
101. Seeman MV, Lang M, Rector N. Chronic schizophrenia: a risk factor for HIV? Can J Psychiatry. 1990;35:765-768.
102. Carney CP, Jones LE. The influence of type and severity of mental illness on receipt of screening mammography. J Gen Intern Med. 2006;21:1097-1104.
103. Aloysi A, Van Dyk K, Sano M. Women's cognitive and affective health and neuropsychiatry. Mt Sinai J Med. 2006;73:967-975.
104. Grigoriadis S, Seeman MV. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry. 2002;47:437-442.
105. Seeman MV. Narratives of twenty to thirty year outcomes in schizophrenia. Psychiatry.1998;61:249-261.
106. Gabay PM, Fernández Bruno M, Roldán E. [Sexual behavior in patients with schizophrenia: a review of the literature and survey in patients attending a rehabilitation program.] Vertex. 2006;17:136-144.
107. MacDonald S, Halliday J, MacEwan T, et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study. Br J Psychiatry. 2003;182:50-56.
108. Seeman MV, Benes C. Problèmes sexuels dans une clinique pour femmes schizophrénes [Sexual problems in a women's clinic for schizophrenia]. Sexologies. 2000;9:12-15.
109. Howes OD, Wheeler MJ, Pilowsky LS, et al. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2007;68:361-367.
110. Ohl LE. Essentials of female sexual dysfunction from a sex therapy perspective. Urol Nurs. 2007;27:57-63.
111. Fan X, Henderson DC, Chiang E, et al. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res. 2007;94:119-127.
112. Chernomas WM, Clarke DE, Chisholm FA. Perspectives of women living with schizophrenia. Psychiatr Serv. 2000;51:1517-1521.
113. Justo D, Prokhorov V, Heller K, et al. Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors. Acta Psychiatr Scand. 2005;111:171-176.
114. Lin CH, Chen MC, Wang SY, et al. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics. J Formos Med Assoc. 2004;103:437-441.
115. Fabijanic D, Culic V, Bozic I, et al. Gender differences in in-hospital mortality and mechanisms of death after the first acute myocardial infarction. Ann Saudi Med. 2006;26:455-460.
116. Howard L, Kirkwood G, Leese M. Risk of hip fracture in patients with a history of schizophrenia. Br J Psychiatry. 2007;190:129-134.
117. Jung DU, Conley RR, Kelly DL, et al. Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study. J Clin Psychiatry. 2006;67:1391-1396.
118. Zhang-Wong JH, Seeman MV. Antipsychotic drugs, menstrual regularity and osteoporosis risk. Arch Womens Ment Health. 2002;5:93-98.
119. Hakko H, Komulainen MT, Koponen H, et al. Are females at special risk of obesity if they become psychotic? The longitudinal Northern Finland 1966 Birth Cohort Study. Schizophr Res. 2006;84:15-19.
120. Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry. 2001;46:549-555.
121. Dickerson FB, Brown CH, Kreyenbuhl JA, et al. Obesity among individuals with serious mental illness. Acta Psychiatr Scand. 2006; 113:306-313.
122. Henderson DC, Borba CP, Daley TB, et al. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry. 2006;18:99-105.
123. Bottai T, Quintin P, Perrin E. Antipsychotics and the risk of diabetes: a general data review. Eur Psychiatry. 2005;20(Suppl 4):S349-S357.
124. Flanagan DE, Vaile JC, Petley GW, et al. Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system. Regul Pept. 2007;140:37-42.
125. Bobes J, Arango C, Aranda P, et al. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr Res. 2007;90:162-173.
126. Aichhorn W, Whitworth AB, Weiss EM, et al. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf. 2006;29:587-598.
127. Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry. 2004;161:1324-1333.
128. Cantor-Graae E. The contribution of social factors to the development of schizophrenia: a review of recent findings. Can J Psychiatry. 2007;52:277-286.
129. McGrath J, Eyles D, Mowry B, et al. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res. 2003;63:73-78.
130. Dealberto MJ. Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Med Hypoth. 2007;68:259-267.
131. Martens WH. Determinants of increased risk of schizophrenia in immigrants. What could be done by our western governments? Med Law. 2006;25:699-713.
132. Warner R. Local projects of the world psychiatric association programme to reduce stigma and discrimination. Psychiatr Serv. 2005;56:570-575.